UTERINE SEROUS CARCINOMA
Clinical trials for UTERINE SEROUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE SEROUS CARCINOMA trials appear
Sign up with your email to follow new studies for UTERINE SEROUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aimed at folate receptor shows promise for tough endometrial cancer
Disease control Recruiting nowThis phase 2 trial tests a drug called mirvetuximab soravtansine in 50 women with a specific type of endometrial cancer that has come back or won't go away. The drug targets a protein called folate receptor alpha, which is often found on these cancer cells. Researchers want to se…
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE2 • Sponsor: Alessandro Santin • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called WJB001 combined with various chemotherapy drugs in people with advanced solid tumors that have not responded to standard treatments. The trial has three stages to find the safest dose, check how the body processes the drug, and see if it shrinks…
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Hard-to-Treat uterine cancer: targeted drug trial underway
Disease control Recruiting nowThis study tests a drug called azenosertib in 25 women with a rare and aggressive type of uterine cancer that has come back or not gone away. The goal is to see how the drug affects cancer cells and whether it can shrink tumors or slow the disease. Participants take the drug and …
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE2 • Sponsor: Joyce Liu, MD • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug SIM0505 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called SIM0505 in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and check for any early signs that the drug shrinks tumors. About 414 participants will re…
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill takes on tough cancers: early trial launches
Disease control Recruiting nowThis study tests a new daily pill, VLS-1488, for people with advanced solid tumors that have not responded to other treatments. About 200 participants with specific cancers like ovarian, lung, or breast cancer will receive the drug to see if it is safe and shrinks tumors. The goa…
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC